Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Unknown 3

Sponsor Class

OTHER_GOV 3OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Hypertension, Portal 3Carcinoma, Hepatocellular 3Colorectal Neoplasms 2Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Liver Cirrhosis 1

Interventions

tislelizumab 4Sorafenib 3Propranolol 3ledipasvir 2entecavir 2donafenib 2apatinib 2Sofosbuvir 2Ribavirin 2Radiotherapy 2Proton Therapy 2Bevacizumab 2sitravatinib 1polysaccharide MGN3 1palbociclib 1lenvatinib 1lens intermediate filament proteins 1ledipasvir, sofosbuvir drug combination 1envafolimab 1elbasvir-grazoprevir drug combination 1daclatasvir 1camrelizumab 1atezolizumab 1anlotinib 1Vitamin D 1Urination 1Tyrosine Kinase Inhibitors 1Surgical Procedures, Operative 1Simeprevir 1Raltegravir Potassium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Carcinoma, Hepatocellular × Propranolol × Clear all
NCT01451658 2019-09-04

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT01970748 2019-08-30

P-HCC

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT01298284 2011-06-15

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡